Gilead Sued In Calif. Over Remdesivir COVID-19 Claims

By Kaitlin Gebby · December 7, 2023, 10:31 PM EST

Patients hospitalized with COVID-19 and their surviving families are suing pharmaceutical company Gilead Sciences Inc. over the antiviral drug remdesivir, alleging the drug that received emergency approval in May 2020 was...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Fust et al v. Gilead Sciences, Inc

Case Number

2:23-at-01244

Court

California Eastern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

December 06, 2023